Ironwood Pharmaceuticals Inc (IRWD): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 6,1 US Dollar | 1 | 1 | 2 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 165.239.947 | 10,5 | 7,16 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Ironwood Pharmaceuticals Inc
Mitarbeiter 100
Handelsplatz NASDAQ
Ticker Symbol IRWD
IPO Datum 2010-02-03
Adresse 100 Summer Street, Boston, MA, United States, 02110
Webseite https://ironwoodpharma.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Thomas A. McCourt | CEO & Director |
| 2 | Mr. Ronald Silver | Senior VP, Interim CFO, Corporate Controller & Chief Accounting Officer |
| 3 | Dr. Rosario Lobrutto M.B.A., M.S., Ph.D. | VP & Global Head of Technical Operations |
| 4 | Mr. John Minardo | Senior VP, Chief Legal Officer & Secretary |
| 5 | Mr. Jeff Ruberti | Chief Strategy Officer |
| 6 | Dr. Jeffrey Silber M.D. | Chief Medical Officer, Head of Research & Drug Development |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | BlackRock Inc | 10,77% | 64,22 Mio. USD |
| 2 | Armistice Capital, LLC | 8,43% | 50,30 Mio. USD |
| 3 | Sarissa Capital Management LP | 5,56% | 33,17 Mio. USD |
| 4 | State Street Corp | 5,33% | 31,80 Mio. USD |
| 5 | Bank of America Corp | 5,26% | 31,35 Mio. USD |
| 6 | Renaissance Technologies Corp | 4,84% | 28,86 Mio. USD |
| 7 | Vanguard Capital Management, LLC | 4,00% | 23,86 Mio. USD |
| 8 | AQR Capital Management LLC | 3,91% | 23,34 Mio. USD |
| 9 | Acadian Asset Management LLC | 3,54% | 21,13 Mio. USD |
| 10 | Vanguard Portfolio Management, LLC | 3,34% | 19,90 Mio. USD |
| 11 | Geode Capital Management, LLC | 2,92% | 17,44 Mio. USD |
| 12 | Two Sigma Investments LLC | 2,76% | 16,45 Mio. USD |
| 13 | Marshall Wace Asset Management Ltd | 2,60% | 15,49 Mio. USD |
| 14 | Jacobs Levy Equity Management, Inc. | 2,46% | 14,68 Mio. USD |
| 15 | The Goldman Sachs Group Inc | 2,01% | 11,96 Mio. USD |
| 16 | Charles Schwab Investment Management Inc | 2,00% | 11,92 Mio. USD |
| 17 | Federated Hermes Inc | 1,96% | 11,67 Mio. USD |
| 18 | Arrowstreet Capital Limited Partnership | 1,83% | 10,89 Mio. USD |
| 19 | Dimensional Fund Advisors, Inc. | 1,53% | 9,11 Mio. USD |
| 20 | Mackenzie Investments | 1,43% | 8,55 Mio. USD |